[Effect of intrauterine progesterone-releasing devices on the hypothalamic-hypophyseal-ovarian axis in women].
D004958:Estradiol / Q000097:blood; D004967:Estrogens / Q000652:urine; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D006801:Humans; D007031:Hypothalamus / Q000378:metabolism; D007434:Intrauterine Devices; D007436:Intrauterine Devices, Medicated; D007986:Luteinizing Hormone / Q000378:metabolism; D008598:Menstruation; D010053:Ovary / Q000378:metabolism; D010903:Pituitary Gland, Anterior / Q000378:metabolism; D011276:Pregnanediol / Q000652:urine; D011374:Progesterone / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*
D004967:Estrogens; D011374:Progesterone; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D011276:Pregnanediol
Effetto dei dispositivi intrauterini liberanti progesterone sull'asse ipotalamo-ipofiso-ovarico nella donna